- Bafilomycin C1
-
- $0.00 / 5mg
-
2025-07-17
- CAS:88979-61-7
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | BAFILOMYCIN C1 Basic information |
| Product Name: | BAFILOMYCIN C1 | | Synonyms: | 2-Demethyl-2-methoxy-24-methylhygrolidin;Antibiotic L-681110A1;L-681110A1;BAFILOMYCIN C1;2-Butenedioic acid (2E)-, 1-[(2R,4R,5S,6R)-tetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-6-(1-methylethyl)-2H-pyran-4-yl] ester;Bafilomycin C1, from Streptomyces griseus;Bafilomycin C-1,Bafilomycin C1;Bafilomycin C1, Vacuolar-type H+-ATPase inhibitor. | | CAS: | 88979-61-7 | | MF: | C39H60O12 | | MW: | 720.89 | | EINECS: | | | Product Categories: | | | Mol File: | 88979-61-7.mol |  |
| | BAFILOMYCIN C1 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO: 5 mg/ml; Methanol: 5 mg/ml | | form | White to light-brown solid. | | color | Yellow |
| | BAFILOMYCIN C1 Usage And Synthesis |
| Uses | Bafilomycin C1 is a member of a potent family of macrocyclic lactones. Bafilomycin C1 shares a similar mode of action and activity as its more accessible A1 analogue. Bafilomycin C1 is broadly active against bacteria, fungi, insects, nematodes and cestodes. Bafilomycin C1 has attracted interest as a potential agent for treating osteoporosis. The presence of the fumarate group provides an ideal ligand for affinity chromatography of V-ATPase. | | Uses | Bafilomycin C1 is a selective, reversible inhibitor of vacuolar H+-ATPases (V-ATPases). It blocks these pumps in mammalian, plant, or fungal cells, preventing proton transport and compartment acidification. Bafilomycin C1 has been shown to have angiostatic activity in the chick chorioallantoic membrane assay. It has also been used, when coupled to cellulose, to purify V-ATPases.[Cayman Chemical] | | in vivo | Bafilomycin C1 (subcutaneous injection; 0.2 mg/kg; 20 days) retards the tumor growth without apparent adverse reactions or side effects in nude mice model[1]. | Animal Model: | BALB/c nude mice (weighing 18-20 g) subcutaneous injected by SMMC7721 cell suspension (5×106 cells/100 μL)[2] | | Dosage: | 0.2 mg/kg | | Administration: | Subcutaneous injection; 20 days | | Result: | Suppressed tumor growth of SMMC7721 tumor xenografts. |
| | IC 50 | Macrolide | | storage | +4°C |
| | BAFILOMYCIN C1 Preparation Products And Raw materials |
|